|
|
Volumn 7, Issue 3, 1998, Pages 361-371
|
|
Interleukin-2 in the treatment of malignant melanoma
|
|
Author keywords
Interleukin 2; Malignant melanoma
|
|
Indexed keywords
ALPHA INTERFERON;
CISPLATIN;
DACARBAZINE;
HLA ANTIGEN;
INTERLEUKIN 2 RECEPTOR;
LEUKOCYTE ANTIGEN;
RECOMBINANT INTERLEUKIN 2;
ADOPTIVE IMMUNOTHERAPY;
ANTIGEN EXPRESSION;
AUTOTRANSPLANTATION;
CELL TRANSPLANTATION;
CONTINUOUS INFUSION;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
HYPOTENSION;
IMMUNOMODULATION;
IMMUNOTHERAPY;
LYMPHOCYTOPENIA;
LYMPHOKINE ACTIVATED KILLER CELL;
MELANOMA;
NATURAL KILLER CELL;
PHENOTYPE;
PROGNOSIS;
REVIEW;
TUMOR ASSOCIATED LEUKOCYTE;
|
|
EID: 0031906826
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.7.3.361 Document Type: Review |
|
Times cited : (5)
|
|
References (83)
|
